2025-10-30 - Analysis Report
Okay, here's an analysis of Prologis Inc. (PLD) based on the data you provided, presented in English with key figures first, followed by analysis:

## PLD (Prologis Inc.) Stock Analysis

Prologis Inc. is a real estate investment trust (REIT) that specializes in logistics facilities.

### 1. Performance vs. S&P 500 (VOO)

*   **PLD Cumulative Return:** 72.90%
*   **VOO Cumulative Return:** 104.04%
*   **Performance Difference:** -24.9%
*   **Relative Performance:** 16.6 (This indicates PLD's performance is in the lower range of its historical divergence from the S&P 500, based on the max/min range.)

**Analysis:** PLD has underperformed the S&P 500 significantly. The relative performance suggests this underperformance is not unusual within its historical range, but still warrants further investigation.

#### Alpha, Beta Analysis:

| Year       | CAGR   | MDD   | Alpha  | Beta | Cap(B) |
| ---------- | ------ | ----- | ------ | ---- | ------ |
| 2015-2017  | 37.0%  | 67.8% | 8.0%   | -0.0 | 59.9   |
| 2016-2018  | 15.0%  | 67.8% | 0.0%   | 0.1  | 54.5   |
| 2017-2019  | 43.0%  | 70.7% | 21.0%  | 0.5  | 82.8   |
| 2018-2020  | 13.0%  | 81.6% | -10.0% | 0.5  | 92.5   |
| 2019-2021  | 98.0%  | 81.6% | 51.0%  | 0.6  | 156.3  |
| 2020-2022  | 3.0%   | 81.6% | 4.0%   | 0.6  | 104.7  |
| 2021-2023  | 21.0%  | 80.7% | 20.0%  | 0.6  | 123.8  |
| 2022-2024  | -65.0% | 80.7% | -86.0% | 0.6  | 98.2   |
| 2023-2025  | -3.0%  | 81.5% | -71.0% | 0.8  | 115.8  |

**Analysis:**

*   **CAGR:** Fluctuating CAGR indicates inconsistent growth over the periods analyzed.  Recent periods show negative or low growth.
*   **MDD:** High Maximum Drawdown (MDD) consistently across all periods suggests significant volatility and potential risk.
*   **Alpha:**  Alpha varies widely, indicating periods of outperformance and underperformance relative to its benchmark.  More recent periods show negative alpha, contributing to the underperformance relative to the S&P 500.
*   **Beta:** Beta remains consistently below 1, indicating lower volatility compared to the overall market.

### 2. Recent Stock Price Movement

*   **Current Price:** 124.65
*   **Previous Close:** 125.72
*   **Change:** -0.85
*   **5-Day Moving Average:** 125.976
*   **20-Day Moving Average:** 120.0352
*   **60-Day Moving Average:** 114.0818

**Analysis:** The stock price decreased slightly in the last market day. The 5-day moving average is above the current price, suggesting a recent downward trend. The 20-day and 60-day moving averages are below the 5-day moving average, indicating a potentially longer-term upward trend, although the short-term trend is currently down.

### 3. Technical Indicators & Expected Return

*   **Market Risk Indicator (MRI):** 0.9 (High Investment Recommended)
*   **RSI:** 64.91 (Approaching overbought territory, but not yet there)
*   **PPO:** 0.4244
*   **Hybrid Signal:** "cash\_0% Buy 100% of cash (9 shares - Very Safe - MRI:0.90)"
*   **Recent (20-Day) Relative Divergence Change:** 9.9 (+, indicating short-term increase in relative performance)
*   **Expected Return:** 56.0% (Long-term excess return vs. S&P 500)

**Analysis:**

*   The MRI suggests the stock is considered a good investment based on its risk profile.
*   The RSI is approaching overbought territory, which could signal a potential pullback.
*   The positive change in relative divergence over the last 20 days suggests some recent positive momentum compared to the S&P 500.
*   The Hybrid Signal recommends fully investing, suggesting a bullish outlook.
*   The expected return is high, indicating significant potential for outperformance over the long term.
*   The 'change': -0.85 from 'previousClose': 125.72 doesn't signal a major price movement.

### 4. Recent News & Significant Events

*   **Analyst Adjustments:** Scotiabank raised its price target to $127, while Evercore ISI lowered theirs to $116.
*   **Earnings Guidance:** Positive earnings guidance and analyst upgrades were mentioned.
*   **Other News:** Other news includes financial stock analysis and real estate investment trusts.

**Analysis:**  The mixed analyst actions (one upgrade, one downgrade) suggest uncertainty in the stock's immediate future. The positive earnings guidance is a good sign. Pay close attention to the reasons behind the price target adjustments.

### 4-2. Analyst Opinions

*   **Consensus:** Buy
*   **Mean Rating:** 1.92 (~Buy)
*   **Number of Opinions:** 20
*   **Target Price (Avg/High/Low):** 129.65 / 145.00 / 116.00

**Analysis:** The analyst consensus is generally positive, with a "Buy" rating and a mean rating close to "Buy". The average target price suggests a potential upside from the current price. The high and low target prices reflect a range of opinions.

### 5. Recent Earnings Analysis

| 날짜         | EPS  | 매출     |
| ------------ | ---- | -------- |
| 2025-10-28 | 0.82 | 2.21 B$ |
| 2025-07-30 | 0.61 | 2.18 B$ |
| 2025-04-29 | 0.64 | 2.14 B$ |
| 2025-02-14 | 1.38 | 2.20 B$ |
| 2024-10-25 | 1.08 | 2.04 B$ |

**Analysis:** The latest EPS is 0.82 and revenue is $2.21B. EPS has fluctuated, and revenue has generally been increasing. The recent increase in EPS and revenue indicates recent growth.

### 6. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
| ------------ | ---------- | ------------- |
| 2025-06-30 | $2.18B     | 74.68%        |
| 2025-03-31 | $2.14B     | 74.34%        |
| 2024-12-31 | $2.20B     | 76.39%        |
| 2024-09-30 | $2.04B     | 76.00%        |
| 2024-06-30 | $2.01B     | 74.31%        |

**Capital and Profitability:**

| Quarter      | Equity      | ROE    |
| ------------ | ----------- | ------ |
| 2025-06-30 | $52.73B    | 1.08%  |
| 2025-03-31 | $53.47B    | 1.11%  |
| 2024-12-31 | $53.95B    | 2.37%  |
| 2024-09-30 | $53.07B    | 1.90%  |
| 2024-06-30 | $53.35B    | 1.61%  |

**Analysis:** Revenue has shown steady growth. Profit margins are consistently high, indicating strong profitability. Equity has remained relatively stable, while ROE has fluctuated.

### 7. Overall Summary

Prologis (PLD) presents a mixed picture. While the MRI gives it a positive recommendation and analyst consensus leans toward "Buy," it has underperformed the S&P 500. Recent earnings and revenue growth are encouraging. However, the negative alpha and underperformance relative to the S&P 500 warrant caution. The high expected return could be attractive for long-term investors.

**Key Considerations:**

*   **Underperformance:**  Investigate the reasons behind PLD's underperformance compared to the S&P 500. Is this a temporary situation or a longer-term trend?
*   **Earnings Growth:** Focus on whether the earnings and revenue growth can be sustained.
*   **Analyst Opinions:** Consider both the consensus and the range of target prices.
*   **Risk Tolerance:** Be aware of the high Maximum Drawdown (MDD) and the associated risk.

**Recommendation:**

A cautious approach is recommended. While the data suggests some positive aspects, the underperformance and mixed analyst opinions call for further due diligence before making a decision.
